What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Myocardial infarction
His primary scientific interests are in Internal medicine, Ischemia, Cardiology, Cardioprotection and Ischemic preconditioning.
His research investigates the connection with Internal medicine and areas like Endocrinology which intersect with concerns in STAT3.
Rainer Schulz interconnects Blockade, Anesthesia, Perfusion and Pharmacology in the investigation of issues within Ischemia.
His studies in Cardiology integrate themes in fields like Tumor necrosis factor alpha, Microcirculation and Creatine kinase.
His Cardioprotection study combines topics in areas such as Heart metabolism, Intensive care medicine, Ageing and Cell biology.
His Ischemic preconditioning research integrates issues from Potassium channel, Protein kinase C, Signal transduction, Connexin and Glibenclamide.
His most cited work include:
- Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning (612 citations)
- A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy (572 citations)
- Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. (508 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Cardiology, Ischemia, Endocrinology and Cardioprotection.
His Internal medicine study is mostly concerned with Myocardial infarction, Heart failure, Blood flow, Circulatory system and Perfusion.
Cardiology is closely attributed to Hibernation in his research.
His work carried out in the field of Ischemia brings together such families of science as Anesthesia, Hibernating myocardium and Pharmacology.
His Cardioprotection research includes elements of Mitochondrion and Cell biology.
His studies deal with areas such as Reactive oxygen species and Mitochondrial permeability transition pore as well as Mitochondrion.
He most often published in these fields:
- Internal medicine (49.33%)
- Cardiology (34.23%)
- Ischemia (29.83%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (49.33%)
- Cardioprotection (16.06%)
- Cardiology (34.23%)
In recent papers he was focusing on the following fields of study:
Rainer Schulz mostly deals with Internal medicine, Cardioprotection, Cardiology, Cell biology and Ischemia.
He regularly links together related areas like Endocrinology in his Internal medicine studies.
His Endocrinology study combines topics from a wide range of disciplines, such as Inflammation and Calcium.
The various areas that he examines in his Cardioprotection study include Bioinformatics, Reactive oxygen species, Intensive care medicine, Mitochondrial permeability transition pore and Ischemic preconditioning.
His research in the fields of Reperfusion injury overlaps with other disciplines such as Transcriptome.
His work in the fields of Myocardial infarction, such as Infarction, overlaps with other areas such as European union.
Between 2017 and 2021, his most popular works were:
- Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. (194 citations)
- Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week. (191 citations)
- Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology (146 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Myocardial infarction
His primary scientific interests are in Cardioprotection, Internal medicine, Myocardial infarction, Reactive oxygen species and Mitochondrion.
His Cardioprotection research entails a greater understanding of Ischemia.
His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Cardiology.
In the subject of general Myocardial infarction, his work in Infarction is often linked to European union, thereby combining diverse domains of study.
His studies deal with areas such as Oxidative stress, Nitric oxide and Ischemic preconditioning as well as Reactive oxygen species.
His Mitochondrion research is multidisciplinary, incorporating elements of Pharmacology and Mitochondrial permeability transition pore.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
